Current uncertainties and future challenges regarding NAD+ boosting strategies

Autor: Borut Poljšak, Vito Kovač, Irina Milisav
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Zdroj: Antioxidants, vol. 11, no. 9, 1637, 2022.
Antioxidants, str. 1-18 : ilustr., Vol. 11, iss. 9, 2022
COBISS-ID: 522976025
ISSN: 2076-3921
Popis: Precursors of nicotinamide adenine dinucleotide (NAD+), modulators of enzymes of the NAD+ biosynthesis pathways and inhibitors of NAD+ consuming enzymes, are the main boosters of NAD+. Increasing public awareness and interest in anti-ageing strategies and health-promoting lifestyles have grown the interest in the use of NAD+ boosters as dietary supplements, both in scientific circles and among the general population. Here, we discuss the current trends in NAD+ precursor usage as well as the uncertainties in dosage, timing, safety, and side effects. There are many unknowns regarding pharmacokinetics and pharmacodynamics, particularly bioavailability, metabolism, and tissue specificity of NAD+ boosters. Given the lack of long-term safety studies, there is a need for more clinical trials to determine the proper dose of NAD+ boosters and treatment duration for aging prevention and as disease therapy. Further research will also need to address the long-term consequences of increased NAD+ and the best approaches and combinations to increase NAD+ levels. The answers to the above questions will contribute to the more efficient and safer use of NAD+ boosters. Nasl. z nasl. zaslona. Opis vira z dne 25. 8. 2022. Članek št. 1637. Abstract. Bibliografija: str. 11-18. ARRS, Programi, Sl, Mehanizmi varovanja zdravja ARRS, Programi, Sl, Aplikativna in bazična fiziologija in patofiziologija v medicini
Databáze: OpenAIRE